© Drug Hunter Inc. 2018-2023
Home > Sulfopin
selective covalent Pin1 inhibitor
oral efficacy in xenograft model
from covalent fragment screen and opt.
bioRxiv, Mar. 21, 2020
Weizmann Institute / Harvard Medical
Sulfopin (Weizmann/Harvard selective covalent Pin1 inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year